GC Aesthetics® 您的终生伴侣
提供高品质的产品,让患者在丰胸过程中充满自信和安全感。
在联合王国注册成立
在法国注册成立
收购 Eurosilicone 和 Nagor
与第六代凝胶一起发布
向解决方案提供商发展
实施创新路线图战略
推出 NOA™, Eve 4.0™ 并发布 10年临床研究。
推出 PERLE™、HydroCone™ 和 GCA Comfort Plus™ 保修服务
Eurosilicone™和Nagor™品牌正在各个层面向GCA®过渡
推出 FixNip™ NRI
推出 Luna XT™
推出 Puregraft® 和 Healena™ 产品
GCA®的与众不同之处
More than 3 million breast implants placed in the last 10 years, supported by published 10-year clinical data demonstrating compelling safety and effectiveness in aesthetic and reconstructive breast surgery.
Our round and anatomical silicone gel breast implants are backed by long-term peer-reviewed studies evaluating safety, patient satisfaction, and revision rates.
Published clinical evidence includes:
- Ten-Year Safety Data for Eurosilicone’s Round and Anatomical Silicone Gel Breast Implants (Aesthetic Surgery Journal Open Forum, 2019)
- Single-Center and Surgeon’s Long-Term (15–19 Years) Patient Satisfaction and Revision Rate of Round Textured Eurosilicone Breast Implants (Aesthetic Surgery Journal, 2021)
This long-term follow-up reinforces our commitment to reliable breast implant performance and evidence-based medical device development.
To design, develop, manufacture, market, and offer best-in-class medical aesthetic solutions that contribute to women’s healthcare, well-being, confidence, empowerment, and overall happiness through safe, reliable breast implant devices placed in the hands of trained and qualified surgeons.
We are committed to advancing standards in breast augmentation and breast reconstruction by combining:
- Clinical research
- Rigorous manufacturing processes
- Regulatory compliance
- Continuous product innovation
To be the partner of choice for women and surgeons around the world, leading in science, reliability, and innovation in breast implant technology and medical aesthetic solutions.
We aim to continuously support the global surgical community by delivering:
- Proven long-term safety data
- Reliable silicone gel implant technology
- Ongoing scientific collaboration
- Responsible and transparent medical innovation
Through our Total Breast Care™ approach, we go beyond devices to support the full surgical journey, from consultation to long-term follow-up, helping surgeons improve patient compliance, optimize outcomes, and expand possibilities in both aesthetic and reconstructive procedures. By integrating solutions across pre-, intra-, and post-surgery, we enable more personalized treatments and support enhancement and hybrid procedures with greater confidence.
GC Aesthetics® 新闻
免责声明
1.Duteille F 等:Eurosilicone 圆形和解剖型硅凝胶乳房假体的十年安全数据。Aesthet Surg J Open Forum.2019;1(2):ojz012.发表于 2019 Apr 27.

